Literature DB >> 14634095

Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells.

Matthew A Burchill1, Christine A Goetz, Martin Prlic, Jennifer J O'Neil, Ian R Harmon, Steven J Bensinger, Laurence A Turka, Paul Brennan, Stephen C Jameson, Michael A Farrar.   

Abstract

Using transgenic mice that express a constitutively active version of STAT5b, we demonstrate that STAT5 plays a key role in governing B cell development and T cell homeostasis. STAT5 activation leads to a 10-fold increase in pro-B, but not pro-T, cells. Conversely, STAT5 signaling promotes the expansion of mature alphabeta T cells (6-fold increase) and gammadelta and NK T cells (3- to 4-fold increase), but not of mature B cells. In addition, STAT5 activation has dramatically divergent effects on CD8(+) vs CD4(+) T cells, leading to the selective expansion of CD8(+) memory-like T cells and CD4(+)CD25(+) regulatory T cells. These results establish that activation of STAT5 is the primary mechanism underlying both IL-7/IL-15-dependent homeostatic proliferation of naive and memory CD8(+) T cells and IL-2-dependent development of CD4(+)CD25(+) regulatory T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14634095     DOI: 10.4049/jimmunol.171.11.5853

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  94 in total

1.  Differential effects of STAT5 and PI3K/AKT signaling on effector and memory CD8 T-cell survival.

Authors:  Timothy W Hand; Weiguo Cui; Yong Woo Jung; Esen Sefik; Nikhil S Joshi; Anmol Chandele; Ying Liu; Susan M Kaech
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-07       Impact factor: 11.205

2.  Interleukin-7 is required for CD4(+) T cell activation and autoimmune neuroinflammation.

Authors:  Brian R Lawson; Rosana Gonzalez-Quintial; Theodoros Eleftheriadis; Michael A Farrar; Stephen D Miller; Karsten Sauer; Dorian B McGavern; Dwight H Kono; Roberto Baccala; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2015-08-25       Impact factor: 3.969

Review 3.  Homeostatic T cell proliferation as a barrier to T cell tolerance.

Authors:  Somia P Hickman; Laurence A Turka
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-09-29       Impact factor: 6.237

4.  Nonredundant roles for Stat5a/b in directly regulating Foxp3.

Authors:  Zhengju Yao; Yuka Kanno; Marc Kerenyi; Geoffrey Stephens; Lydia Durant; Wendy T Watford; Arian Laurence; Gertraud W Robinson; Ethan M Shevach; Richard Moriggl; Lothar Hennighausen; Changyou Wu; John J O'Shea
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

5.  Molecular orchestration of differentiation and function of regulatory T cells.

Authors:  Li-Fan Lu; Alexander Rudensky
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

6.  Interleukin-7 receptor signaling is deficient in CD4+ T cells from HIV-infected persons and is inversely associated with aging.

Authors:  Douglas A Bazdar; Magdalena Kalinowska; Scott F Sieg
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

7.  Beta-catenin expression enhances IL-7 receptor signaling in thymocytes during positive selection.

Authors:  Qing Yu; Mai Xu; Jyoti Misra Sen
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

8.  Identification of Cellular Sources of IL-2 Needed for Regulatory T Cell Development and Homeostasis.

Authors:  David L Owen; Shawn A Mahmud; Kieng B Vang; Ryan M Kelly; Bruce R Blazar; Kendall A Smith; Michael A Farrar
Journal:  J Immunol       Date:  2018-05-04       Impact factor: 5.422

9.  Ex vivo expansion of memory CD8 T cells from lymph nodes or spleen through in vitro culture with interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  J Immunol Methods       Date:  2009-03-17       Impact factor: 2.303

10.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.